Immunovant, Inc. IMVT Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Immunovant, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Immunovant, Inc.’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immunovant, Inc.'s total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immunovant, Inc.'s total liabilities?
- Immunovant, Inc. (IMVT) reported total liabilities of $104.42M in Q1 2026.
- How has Immunovant, Inc.'s total liabilities changed year-over-year?
- Immunovant, Inc.'s total liabilities increased by 51.8% year-over-year, from $68.78M to $104.42M.
- What is the long-term trend for Immunovant, Inc.'s total liabilities?
- Over 5 years (2021 to 2026), Immunovant, Inc.'s total liabilities has grown at a 37.8% compound annual growth rate (CAGR), from $21.01M to $104.42M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.